|
New Registered Products
 No-Dol
No-Dol Flu
No-Dol Broncho
No-Dol Rheumo
Lamicon
Cratal
Venohepanol
ATF-Long
Corvitin
Itracon
Farmadex
Liprazid
Omesan 20
|
|
New products
|
|
|
CRATAL
shows a soft cardiotonic effect, antianginal,
coronarolyhtic and anti-arrhythmic
activity as well as antihypoxial and
anti-aggregate effects. It reduces
symptoms of digitalis intoxication,
improves workability, the frame of
mind and provides a sedative effect.
INDICATIONS. Neurocirculatory dystonia,
vegetovascular dystonia; combined
therapy with chronic cardiac ischemia,
idiopathic dilatation cardiomyopathy
complicated with development of blood
circulation insufficiency, I-III degrees
of hypertension, postradiation syndrome. |
|
|
| |
Anti-inflammatory
and anti-thrombotic agent for external
use.
INDICATIONS. Prevention and treatment
of varicosis, thrombosis, thrombophlebitis,
inflammatory infiltrates, crus ulcer
with local blood circulation failure,
hemorrhagic vein thrombophlebitis;
close injuries (including sporting
ones) with hematoma, contusion, strain,
etc. and tendovaginitis. It is also
used for improving healing processes
of post-operation cicatrices; cicatric
indurations; external inflammatory
processes and infiltrates (abscess,
furunculosis, bedsore, intertrigo,
mammilla cracks and inflammation during
lactation period). |
|
|
| |
| Nasal
drops. Drug has anti-inflammatory
and anti-edematous action, decreases
intensity of local exudative reactions,
decreases the viscosity of the secret
of mucosa of the respiratory tract. |
|
|
| |
| ATP-LONG®
is a unique medicine of a new class
of substances, consists of adenosine-5`-triphosphate
(ATP), histidine amino acid, magnesium
and potassium. ATP-LONG® shows
anti-ischemia, membrane stabilizing
and anti-arrhythmic effects. ATP-LONG®
normalizes energetic metabolism, improves
myocardium anti-oxidation protection
system, reduces accumulation in membranes
of hydrolysis products and peroxidation
of phospholipids. ATP-LONG® improves
indicators of central and peripheral
hemodynamics, of coronary blood circulation,
raises myocardium contractile ability,
functional status of left ventricle
and cardiac ejaculation resulting
in better indicator of physical working
capacity. ATP-LONG® reduces frequency
of stenocardia, normalizes potassium
and magnesium concentrations in tissues
and reduces uric concentration. |
|
|
|
|
|
